Which point-of-care diagnostic technology was first approved for retail pharmacy use, creating a new category of consumer-accessible medical testing?

The healthcare retail landscape is rapidly evolving with innovative point-of-care diagnostic technologies transforming how patients access medical testing. These systems, available in retail pharmacies and clinics, represent a significant shift in healthcare delivery and consumer behavior. How well do you understand this emerging trend at the intersection of medical technology and retail healthcare?

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Abbott's ID NOW rapid molecular testing platform (2020)
Theranos Edison blood testing machine (2013)
Cepheid GeneXpert Omni system (2018)
Alere (now Abbott) INRatio PT/INR monitoring system (2003)